JARID2 and the PRC2 complex regulate skeletal muscle differentiation through regulation of canonical Wnt signaling
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
JARID2 and the PRC2 complex regulate skeletal muscle differentiation through regulation of canonical Wnt signaling
Authors
Keywords
jarid2, Ezh2, Wnt, Sfrp1, MyoD
Journal
Epigenetics & Chromatin
Volume 11, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-08-17
DOI
10.1186/s13072-018-0217-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of Methyltransferase Setd7 Allows the In Vitro Expansion of Myogenic Stem Cells with Improved Therapeutic Potential
- (2018) Robert N. Judson et al. Cell Stem Cell
- Knockdown of JARID2 inhibits the proliferation and invasion of ovarian cancer through the PI3K/Akt signaling pathway
- (2017) Jian Cao et al. Molecular Medicine Reports
- Wnt Signaling in Rhabdomyosarcoma - A Potential Targeted Therapy Option
- (2016) Eleanor Chen CURRENT DRUG TARGETS
- A role for the Wnt3a/β-catenin signaling pathway in the myogenic program of C2C12 cells
- (2016) S. Thomas Abraham IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
- Wnt signaling in cancer
- (2016) T Zhan et al. ONCOGENE
- β-Catenin Activation in Muscle Progenitor Cells Regulates Tissue Repair
- (2016) Anja Rudolf et al. Cell Reports
- Wnt3a signal pathways activate MyoD expression by targetingcis-elements inside and outside its distal enhancer
- (2015) Yu Chih Pan et al. BIOSCIENCE REPORTS
- Secreted Frizzled-Related Protein 3 (SFRP3) Is Required for Tumorigenesis of PAX3-FOXO1-Positive Alveolar Rhabdomyosarcoma
- (2015) J. J. G. Kephart et al. CLINICAL CANCER RESEARCH
- miRNA-204 drives cardiomyocyte proliferation via targeting Jarid2
- (2015) Dandan Liang et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Jarid2 Coordinates Nanog Expression and PCP/Wnt Signaling Required for Efficient ESC Differentiation and Early Embryo Development
- (2015) David Landeira et al. Cell Reports
- Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMS
- (2014) Roberta Ciarapica et al. BMC CANCER
- Disulfide Bond Requirements for Active Wnt Ligands
- (2014) Bryan T. MacDonald et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Characterization of Wnt/β-catenin signaling in rhabdomyosarcoma
- (2013) Srinivas R Annavarapu et al. LABORATORY INVESTIGATION
- JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells
- (2013) Z S Walters et al. ONCOGENE
- Interferon- Resets Muscle Cell Fate by Stimulating the Sequential Recruitment of JARID2 and PRC2 to Promoters to Repress Myogenesis
- (2013) P. Londhe et al. Science Signaling
- Genome-wide binding of the basic helix-loop-helix myogenic inhibitor musculin has substantial overlap with MyoD: implications for buffering activity
- (2013) Kyle L MacQuarrie et al. Skeletal Muscle
- Wnt signaling in myogenesis
- (2012) Julia von Maltzahn et al. TRENDS IN CELL BIOLOGY
- EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes -Catenin-Dependent Hepatocarcinogenesis
- (2011) A. S. L. Cheng et al. CANCER RESEARCH
- Coordinated regulation of differentiation and proliferation of embryonic cardiomyocytes by a jumonji (Jarid2)-cyclin D1 pathway
- (2011) K. Nakajima et al. DEVELOPMENT
- Polycomb-mediated repression during terminal differentiation: what don't you want to be when you grow up?
- (2011) M. L. Conerly et al. GENES & DEVELOPMENT
- Polycomb EZH2 controls self-renewal and safeguards the transcriptional identity of skeletal muscle stem cells
- (2011) A. H. Juan et al. GENES & DEVELOPMENT
- Jarid2 (Jumonji, AT Rich Interactive Domain 2) RegulatesNOTCH1Expression via Histone Modification in the Developing Heart
- (2011) Matthew R. Mysliwiec et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Endothelial Jarid2/Jumonji Is Required for Normal Cardiac Development and Proper Notch1 Expression
- (2011) Matthew R. Mysliwiec et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genome-wide remodeling of the epigenetic landscape during myogenic differentiation
- (2011) P. Asp et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chromatin regulated interchange between polycomb repressive complex 2 (PRC2)-Ezh2 and PRC2-Ezh1 complexes controls myogenin activation in skeletal muscle cells
- (2011) Lovorka Stojic et al. Epigenetics & Chromatin
- Sequential association of myogenic regulatory factors and E proteins at muscle-specific genes
- (2011) Priya Londhe et al. Skeletal Muscle
- TNF/p38α/Polycomb Signaling to Pax7 Locus in Satellite Cells Links Inflammation to the Epigenetic Control of Muscle Regeneration
- (2010) Daniela Palacios et al. Cell Stem Cell
- Jarid2 and PRC2, partners in regulating gene expression
- (2010) G. Li et al. GENES & DEVELOPMENT
- JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells
- (2010) Diego Pasini et al. NATURE
- Jarid2/Jumonji Coordinates Control of PRC2 Enzymatic Activity and Target Gene Occupancy in Pluripotent Cells
- (2009) Jamy C. Peng et al. CELL
- Jumonji Modulates Polycomb Activity and Self-Renewal versus Differentiation of Stem Cells
- (2009) Xiaohua Shen et al. CELL
- A Temporal Switch from Notch to Wnt Signaling in Muscle Stem Cells Is Necessary for Normal Adult Myogenesis
- (2008) Andrew S. Brack et al. Cell Stem Cell
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started